Treatment of Patients With Blepharitis and Facial Rosacea

Completed · Phase 2 · Has a placebo group

Conditions studied: Blepharitis, Meibomianitis, Dry Eye

In brief

To determine the safety and efficacy of sub-antimicrobial dose COL-101 in the treatment of patients who have both blepharitis and facial rosacea

Key facts

Study ID

NCT00560703

Run by

Galderma R&D

People needed

70

Starts

2007-11-01

Expected to finish

2009-07-01

Last updated by the study team

2021-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• blepharitis
• facial rosacea

You may not qualify if…

• pregnant or nursing women
• allergy to tetracyclines
• recent eye surgery
• past or current use of isotretinoin
• patients who are achlorhydric
• patients who have had gastric by-pass surgery

Where it is running

• Pleasant Valley Ophthalmology — Little Rock, Arkansas, United States
• Warren Scherer, MD — Naples, Florida, United States
• Kentucky Lions Eye Center — Louisville, Kentucky, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Marguerite McDonald, MD — Lynbrook, New York, United States
• Dean McGee Eye Institute — Oklahoma City, Oklahoma, United States
• Anita Nevyas-Wallace, MD — Bala-Cynwyd, Pennsylvania, United States
• Tanner Clinic — Layton, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.